Victrex (NASDAQ:VTXPF) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a research note issued on Tuesday.

According to Zacks, “Victrex Plc engages in the manufacture and marketing of polymers. The company offers products under the Victrex, Aptiv, Vicote and Victrex Pipes brands. It operates through the Victrex Polymer Solutions and Invibio Biomaterial Solutions segments. Victrex Polymer Solutions segment focuses on the automotive, aerospace, electronics and energy markets. Invibio Biomaterial Solutions provides solutions for medical device manufacturers. Victrex Plc is headquartered in Thornton Cleveleys, United Kingdom. “

Victrex (VTXPF) remained flat at $$32.90 during trading on Tuesday. The stock had a trading volume of 90 shares, compared to its average volume of 211. Victrex has a fifty-two week low of $21.00 and a fifty-two week high of $33.20.

TRADEMARK VIOLATION WARNING: “Victrex (VTXPF) Downgraded by Zacks Investment Research” was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another website, it was copied illegally and republished in violation of United States and international copyright law. The correct version of this report can be viewed at https://www.thecerbatgem.com/2017/11/07/victrex-vtxpf-downgraded-by-zacks-investment-research.html.

Receive News & Stock Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related stocks with our FREE daily email newsletter.